Navigation Links
ViroPharma Provides Update on Vancocin(R)
Date:1/8/2008

EXTON, Pa., Jan. 8 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today provided the following update on its petition to the U.S. Food and Drug Administration (FDA) regarding Vancocin(R) (vancomycin hydrochloride capsules).

As part of the company's continuing efforts to assure the safety of patients afflicted with Clostridium difficile infection, ViroPharma yesterday presented its views on the in vitro dissolution bioequivalence method proposed by OGD, as well as important related health and safety information, to officials in the FDA's Office of Pharmaceutical Sciences (OPS), Office of Generic Drugs (OGD) and FDA legal counsel. ViroPharma appreciates the FDA's time and attention to this matter.

Consistent with the eventual availability of the slides presented by ViroPharma at the meeting in the FDA Docket for ViroPharma's petition on this matter, ViroPharma has posted these slides to its corporate website (http://www.viropharma.com/OGDpetition/).

Additionally, the company notes that the FDA's website docket at times experiences a delay in making Citizens Petition and supplement submissions available for public review through the internet. In the interest of transparency, ViroPharma also has posted to its website the following supplement submissions previously filed by ViroPharma, but which are not yet available on the FDA's website:
-- December 2007 Docket submission by ViroPharma detailing how ViroPharma

believes the OGD's actions regarding Vancocin are illustrative of

larger systemic problems at the OGD, and amending the company's

petition to request that the FDA take appropriate additional cor
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. ViroPharma Augments Senior Management
2. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
3. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
4. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
5. ViroPharma to Present at the UBS Global Life Sciences Conference
6. ViroPharma to Present at the Maxim Group First Annual Growth Conference
7. HearAtLast Holdings, Inc. Provides Shareholder Update
8. Mayo Clinic Proceedings provides forum for debate about capital punishment
9. Kaiser Permanente Provides $1.4 Million in Holiday Gifts to 40 Metro Atlanta Nonprofits
10. Akela Pharma provides corporate update
11. Genomic Health Announces Oncotype DX(R) Provides Additional Prognostic Benefit in Patients Assessed With Adjuvant Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 2013 Although obesity is associated with ... between obesity and esophageal adenocarcinoma, a type of esophageal ... As reported on Cancer.gov, last reviewed in ... as likely as those of normal and healthy weight ... obesity and esophageal cancer is not well understood, it ...
(Date:5/18/2013)... May 18, 2013 Show And Go Training, ... various different training systems that is all about is getting ... the attention of http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting ... is a unique “four phase system” designed to make you ... of time spent working out in the gym. The training ...
(Date:5/18/2013)... Losing weight remains to be the biggest ... of new weight loss products available in the market today, ... about this newest weight loss supplement prove that dieting and ... Garcinia Cambogia is a sub-tropical fruit that is shaped like ... can suppress a person’s appetite, while it effectively burns fat ...
(Date:5/18/2013)... John Ravera, D.D.S., a Newport Beach ... new member to his dental team, Courtney Marino. , Marino ... for over 10 years. She received her degree from West ... a member of Sigma Pi Alpha, a national honor society ... with patients of all ages, helping them understand the importance ...
(Date:5/18/2013)... UT (PRWEB) May 18, 2013 Medical device ... orders for its much anticipated mobility aid with its namesake, ... create a hands-free crutch alternative that injured individuals ... broken ankle, for example, can remain active and walk during ... is using its reservation system to ensure those who need ...
Breaking Medicine News(10 mins):Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:FlexLeg Begins Offering New Mobility Aid 2
... Mental health screening has been demonstrated to successfully connect ... with school-based mental health services, according to results of ... for Mental Health Checkups at Columbia University. The study ... the Community Mental Health Journal . ...
... C., -- June 14, 2011 Over the past ... and promise of personalized medicine. Scientists are just beginning ... populations in regards to disease prevention and treatment. ... and the laboratories of Floyd H. "Ski" Chilton, Ph.D., ...
... , TUESDAY, June 14 (HealthDay News) -- Some ... -- especially young white girls who are being pushed by ... a new study. "There is a significant amount ... to minimize body weight, but this pressure as it relates ...
... 2011 News media registration is now open for ... in Denver, Aug. 28-Sept. 1, 2011. The event will include ... health, food and nutrition, energy, the environment, and other fields ... of the largest scientific conferences of 2011, the meeting will ...
... The European Society of Cardiology (ESC) Working Group of Atherosclerosis ... the profile of vulnerable plaques and the need for greater ... paper, published online today in Thrombosis and Haemostasis , ... plaque rupture, and for the development of better diagnostics and ...
... By Amanda Gardner HealthDay Reporter , MONDAY, ... support for privatizing Medicare, even though most people agree the ... if it is to survive. Instead, respondents to ... June said the program should be shored up, in part, ...
Cached Medicine News:Health News:Screening helps African-American students connect with school-based mental health services 2Health News:Screening helps African-American students connect with school-based mental health services 3Health News:Ancestry plays vital role in nutrition and disease, study shows 2Health News:Ancestry plays vital role in nutrition and disease, study shows 3Health News:Young Girls May Lose Sleep Over Pressure to Be Thin 2Health News:ESC calls for research into vulnerable plaques 2Health News:Poll Finds Little Support for GOP Plan to Privatize Medicare 2Health News:Poll Finds Little Support for GOP Plan to Privatize Medicare 3
(Date:5/17/2013)... 17, 2013 Research explores ... outcomes research also   to   be presented ... SHPG ), the global specialty biopharmaceutical company, announces that ... at the American Psychiatric Association (APA) 166th Annual Meeting ... The data being presented represent Shire,s ongoing commitment to ...
(Date:5/17/2013)...  ConvaTec today announced that it will report its 2013 first quarter ... CEO, and Ed Borkowski , CFO, will host an ... To participate in the conference call within the U.S. and ... in the conference call outside the U.S. and Canada ... Participants should dial in 10 minutes prior to the start ...
(Date:5/17/2013)... Puerto Rico , May 17, 2013 /PRNewswire/ ... western Puerto Rico , Caribbean Imaging and ... has improved its radiation therapy capabilities with the acquisition of ... Puerto Rico . Versa HD offers clinicians the versatility ... tumors throughout the body, while also enabling treatment of highly ...
Breaking Medicine Technology:Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... BPH, Clinical Benefit After Ozarelix Was Maintained For ... Up ... End Or Soon Thereafter, IRVINE, Calif., Sept. 5 Spectrum,Pharmaceuticals, Inc., ... for ozarelix, the Company,s drug candidate for the,treatment of benign prostatic hypertrophy ...
... analyses of three-year,follow-up data showed that the CYPHER(R) ... to bypass surgery in patients,with blockages in two ... presented this week at the European Society of ... these analyses sought to assess the long-term impact ...
Cached Medicine Technology:Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 2Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 3Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 4Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 5Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 2Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 3Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 4Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 5
...
Tip is bent towards port for downward irrigation. 25G x 7/8in (.50 x 16mm)...
... LASIK surgery and other types of ... corneal interface and/or stromal bed. Flattened ... flap and helps elevate the flap ... x 7/8in (.40 x 22mm) Formed ...
... LASIK surgery and other types of refractive ... and/or stromal bed. Flattened tip provides easy ... the flap edge. Multiple ports provide multi-directional ... Formed 9mm from end tip flattened 1.5mm ...
Medicine Products: